Proteotype Diagnostics awarded £1.5 million Cancer Mission Grant to advance early cancer detection with innovative Enlighten™ test
We are delighted to report that our client, Proteotype Diagnostics Ltd, has just been awarded a £1.5 million Cancer Mission Grant to advance the groundbreaking work they have been doing in early cancer detection with their innovative Enlighten™ test.